Cowen Investment Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Cowen Investment Management’s Portfolio EUCR Stock Details EUCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$501K	–	231
2022 Q3	$501K	Hold	50,000	–	–	0.11%	204
2022 Q2	$495K	Sell	50,000 -74,726	-60%	-$739K	0.11%	206
2022 Q1	$1.23M	Hold	124,726	–	–	0.26%	80
2021 Q4	$1.22M	Buy	124,726 +74,726	+149%	+$732K	0.26%	72
2021 Q3	$489	Hold	50,000	–	–	﹤0.01%	180
2021 Q2	$492K	Hold	50,000	–	–	0.13%	160
2021 Q1	$499K	Buy	+50,000	New	+$513K	0.19%	126

Other funds holding EUCR

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Cowen Investment Management's EUCR Position: Q4 2022 in Review

Cowen Investment Management sold out of Eucrates Biomedical Acquisition Corp. Ordinary Shares (EUCR) in Q4 2022, closing a stake of 50,000 shares — an estimated $501K sold.

Cowen Investment Management first reported a position in EUCR in Q1 2021 and held it in 7 quarters. The position peaked at $1.23M in Q1 2022. 5 funds tracked by Wall St. Rank hold EUCR as of Q4 2022.

Cowen Investment Management reported no remaining Eucrates Biomedical Acquisition Corp. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Cowen Investment Management sold 50,000 Eucrates Biomedical Acquisition Corp. Ordinary Shares shares in Q4 2022, an estimated $501K.
Cowen Investment Management first reported a position in Eucrates Biomedical Acquisition Corp. Ordinary Shares in Q1 2021 and held it in 7 quarters.
Cowen Investment Management's Eucrates Biomedical Acquisition Corp. Ordinary Shares position peaked at $1.23M in Q1 2022.
5 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Ordinary Shares as of Q4 2022.

Based on Cowen Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.